Login
$AIDX
$0.23 -$0.00 (1.15%) Close

$AIDX 8-K SEC Filings

Filed On Filing
18 Sep 2026 8-K: Submission of Matters to a Vote of Security Holders

As previously disclosed, on August 18, 2026, 20/20 Biolabs, Inc. (the “Company”) convened its annual meeting of stockholders of the Company (the “Annual Meeting”). At the Annual Meeting, the Company did not receive a sufficient number of...

10 Sep 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

02 Sep 2026 8-K: Regulation FD Disclosure
19 Aug 2026 8-K: Submission of Matters to a Vote of Security Holders
17 Aug 2026 8-K: Results of Operations and Financial Condition
05 Aug 2026 8-K: Regulation FD Disclosure
22 Jul 2026 8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule
01 Jul 2026 8-K: Regulation FD Disclosure
26 May 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
20 May 2026 8-K: Results of Operations and Financial Condition
28 Apr 2026 8-K: Entry into a Material Definitive Agreement
01 Apr 2026 8-K: Results of Operations and Financial Condition

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support